Clinical Trial Update: Etrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative Colitis [Phase 2]

View source ↗

Summary

Pfizer-sponsored Phase 2 trial comparing etrasimod to placebo in moderately active ulcerative colitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Etrasimod (etrasimod)

Snippet

Sponsor: Pfizer | Conditions: Ulcerative Colitis | Phase 2 | Status: COMPLETED | Results posted: 2025-07-15